The Klinique Medical Clinic PCL (BKK:KLINIQ)

BKK:KLINIQ Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	427.68	314.71	247.91	108.48	464.44	75.91
Short-Term Investments	343.58	402.6	530.63	1,060	1,000	-
Cash & Short-Term Investments	811.45	717.31	778.54	1,168	1,464	75.91
Cash Growth	2.81%	-7.87%	-33.37%	-20.21%	1829.24%	717.54%
Accounts Receivable	15.61	12.2	7.32	12.44	2.88	1.47
Other Receivables	-	0.58	0.04	-	-	-
Receivables	15.61	12.78	7.36	12.44	2.88	1.47
Inventory	401.14	384.52	271.63	191.09	120.05	84.24
Prepaid Expenses	43.03	41.9	29.46	25.34	17.95	5.57
Other Current Assets	98.6	81.39	57.21	79.93	72.24	35.26
Total Current Assets	1,370	1,238	1,144	1,477	1,678	202.44
Property, Plant & Equipment	1,850	1,877	1,795	1,216	818.35	534.11
Long-Term Investments	-	-	-	0.1	-	-
Other Intangible Assets	3.27	3.65	4.51	3.7	3.65	2.31
Long-Term Deferred Tax Assets	9.26	10.42	10.92	6.61	3.14	-
Other Long-Term Assets	221	210.38	163.62	142.29	87.55	75.44
Total Assets	3,453	3,339	3,118	2,846	2,590	814.3

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	143.83	167.49	117.36	88.79	62.87	32.78
Accrued Expenses	90.98	91.09	86.29	85.32	71.81	53.1
Current Portion of Leases	163.02	147.14	127.72	90.45	70.82	58.1
Current Income Taxes Payable	63.53	51.22	39.17	30.55	20.9	20.43
Current Unearned Revenue	534.84	466.42	405.76	400.82	403.31	288.76
Other Current Liabilities	116.1	96.94	88.69	70.04	75.69	45.75
Total Current Liabilities	1,112	1,020	864.98	765.97	705.4	498.92
Long-Term Leases	483.76	530.32	530.33	371.01	234.29	148.89
Pension & Post-Retirement Benefits	4.39	3.99	2.56	2.5	1.45	1.24
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.37
Other Long-Term Liabilities	3.34	3.34	3.34	3.34	3.36	3.38
Total Liabilities	1,604	1,558	1,401	1,143	944.5	653.79

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	110	110	110	110	110	80
Additional Paid-In Capital	1,415	1,415	1,415	1,415	1,415	12.29
Retained Earnings	314.74	247.08	203.03	188.92	131.85	79.49
Comprehensive Income & Other	1.13	1.13	-11.27	-11.27	-11.27	-11.27
Total Common Equity	1,841	1,773	1,717	1,703	1,646	160.5
Minority Interest	8.38	7.93	0	-	-	-
Shareholders' Equity	1,849	1,781	1,717	1,703	1,646	160.5
Total Liabilities & Equity	3,453	3,339	3,118	2,846	2,590	814.3

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	646.79	677.45	658.04	461.46	305.1	206.99
Net Cash (Debt)	164.66	39.85	120.5	707.02	1,159	-131.08
Net Cash Growth	27.02%	-66.92%	-82.96%	-39.02%	-	-
Net Cash Per Share	0.75	0.18	0.55	3.21	6.83	-0.82
Filing Date Shares Outstanding	220	220	220	220	220	160
Total Common Shares Outstanding	220	220	220	220	220	160
Working Capital	257.52	217.59	279.22	711.32	972.16	-296.48
Book Value Per Share	8.37	8.06	7.80	7.74	7.48	1.00
Tangible Book Value	1,838	1,770	1,712	1,699	1,642	158.2
Tangible Book Value Per Share	8.35	8.04	7.78	7.72	7.46	0.99
Buildings	-	342.2	322.49	240.73	184.81	128.06
Machinery	-	1,569	1,387	989.11	711.57	514.16
Construction In Progress	-	22.16	9.34	17.43	11.2	13.29

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error